MAB8261
Anti-Influenza A Antibody, H1N1, clone 9B3.2
clone 9B3.2, Chemicon®, from mouse
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Código UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Productos recomendados
origen biológico
mouse
Nivel de calidad
forma del anticuerpo
purified immunoglobulin
clon
9B3.2, monoclonal
reactividad de especies
human
fabricante / nombre comercial
Chemicon®
técnicas
immunofluorescence: suitable
isotipo
IgG2a
Condiciones de envío
wet ice
Especificidad
Influenza A H1N1 antigen. No reactivity shown to Influenza B strains.
SPECIES REACTIVITY:
Reacts strongly with the following H1N1 strain: Beijing. A/ Texas /36/91, A/Berkeley/1/98, A/HongKong/503/97,A/Nanchang /16A/98,A/PR8/34 and New Caledoniastrain.
SPECIES REACTIVITY:
Reacts strongly with the following H1N1 strain: Beijing. A/ Texas /36/91, A/Berkeley/1/98, A/HongKong/503/97,A/Nanchang /16A/98,A/PR8/34 and New Caledoniastrain.
Inmunógeno
Epitope: H1N1
Influenza blend
Aplicación
IF
Optimal dilutions must be determined by end user
Optimal dilutions must be determined by end user
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Influenza A Antibody, H1N1, clone 9B3.2 is validated for use in IF for the detection of Influenza A.
Forma física
Format: Purified
Purified immunoglobulin. Liquid in 0.02 M Phosphate Buffer + 0.25 M Sodium Chloride + 0.1% Sodium Azide, pH = 7.6
Almacenamiento y estabilidad
Store at 2° to 8°C for up to 12 months from date of receipt.
Otras notas
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Información legal
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Cláusula de descargo de responsabilidad
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Código de clase de almacenamiento
10 - Combustible liquids
Clase de riesgo para el agua (WGK)
WGK 2
Punto de inflamabilidad (°F)
Not applicable
Punto de inflamabilidad (°C)
Not applicable
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Evolution of the influenza A virus genome during development of oseltamivir resistance in vitro.
Renzette, N; Caffrey, DR; Zeldovich, KB; Liu, P; Gallagher, GR; Aiello, D; Porter et al.
Journal of virology null
Detection of mouse-adapted human influenza virus in the olfactory bulbs of mice within hours after intranasal infection.
Jeannine A Majde,Stewart G Bohnet,Georgeann A Ellis,Lynn Churchill,Victor Leyva-Grado et al.
Journal of Neurovirology null
Kristina L Prachanronarong et al.
Journal of virology, 93(2) (2018-11-02)
Influenza A virus (IAV), a major cause of human morbidity and mortality, continuously evolves in response to selective pressures. Stem-directed, broadly neutralizing antibodies (sBnAbs) targeting the influenza virus hemagglutinin (HA) are a promising therapeutic strategy, but neutralization escape mutants can
Li Jiang et al.
Journal of virology, 96(6), e0198221-e0198221 (2022-01-20)
Many oseltamivir resistance mutations exhibit fitness defects in the absence of drug pressure that hinders their propagation in hosts. Secondary permissive mutations can rescue fitness defects and facilitate the segregation of resistance mutations in viral populations. Previous studies have identified
Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus.
Hendricks, GL; Weirich, KL; Viswanathan, K; Li, J; Shriver, ZH; Ashour, J; Ploegh et al.
The Journal of Biological Chemistry null
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico